Viejo, Crispo B.

HRN: 27-17-83  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/30/2025
06/06/2025
IVTT
2.25g
Q6H
Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: